Work

A first-in-human, phase I safety and pharmacokinetic study of genz-644282, a non-camptothecin topoisomerase I inhibitor, in patients with advanced solid tumors.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.2534

Authors: Hyo S. Han, Antoinette R. Tan, Glen J. Weiss, Daniel Sullivan, Jonathan R. Strosberg, Sara Collins, Rebecca Anne Moss, Jingyang Wu, Reginald Ewesuedo, Patricia LoRusso

Institutions: Moffitt Cancer Center, Rutgers Cancer Institute, The Barbara Ann Karmanos Cancer Institute

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2965991858

Cites:

Cited by: 1

Related to: 10